| ORIGINAL ARTICLE |
|
| Year : 2018 | Volume
: 11
| Issue : 12 | Page : 688-692 |
|
|
Can miRNA712_3p be a promising biomarker for early diagnosis of toxoplasmosis?
Nermine Mogahed Fawzy Hussein Mogahed1, Safaa Ibrahim Khedr1, Rasha Abdelmawla Ghazala2, Inas Mohamed Masoud3
1 Medical Parasitology Department, Faculty of Medicine, Alexandria University, Egypt
2 Medical Biochemistry Department, Faculty of Medicine, Alexandria University, Egypt
3 Pharmaceutical Chemistry, Faculty of Pharmacy and Drug Manufacturing, Pharos University in Alexandria, Alexandria, Egypt
Correspondence Address:
Nermine Mogahed Fawzy Hussein Mogahed
Medical Parasitology Department, Faculty of Medicine, Alexandria University
Egypt
 Source of Support: None, Conflict of Interest: None  | 6 |
DOI: 10.4103/1995-7645.248341
|
|
|
Objective: To assess the role of miRNA712_3p as a specific biomarker in early detection of toxoplasmosis in plasma of mice acutely infected with Toxoplasma gondii. Methods: Real-time PCR was used to measure the level of miRNA712_3p in plasma of infected mice. Immune-competent and immune-suppressed mice were examined, three and five days post-infection. Results: Results revealed significant up-regulation of plasma miRNA712_3p in both immune- competent and immune-compromised groups in comparison to the control non-infected group. Additionally, an increase in the level of miRNA712_3p was noticed correspondently in the parasite density detected in liver impression smears. Conclusions: miRNA712_3p can be used as a novel biomarker for the detection of Toxoplasma gondii infection in both immune-competent and immune-compromised host. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
